Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic characterization of Artequick and Coarsucam in healthy Vietnamese volunteers
ACTRN12609000846224Phase 2Not yet recruiting
- Sponsor
- Australian Department of Defence
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Artequick and artesunate + amodiaquine in Malaria (2 arms), sponsored by Australian Department of Defence. Primary endpoints: Pharmacokinetics of Artequick and Coarsucam components and Safety and tolerability. Planned start Oct 2009; status: not yet recruiting.
02
Drugs
Artequickartesunate + amodiaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12609000846224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000846224.